Mitochondrial E3 Ubiquitin Protein Ligase 1 (MUL1) Peptide
-
- Target See all MUL1 products
- MUL1 (Mitochondrial E3 Ubiquitin Protein Ligase 1 (MUL1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GMQYYLSSQD FDSLLQRQES SVRLWKVLAL VFGFATCATL FFILRKQYLQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of C1 orf166 antibody,
Alternative Names: C1ORF166 control peptide, C1ORF166 antibody Blocking Peptide, Anti-C1ORF166 Blocking Peptide, FLJ12875 Blocking Peptide, RP11-401M16.2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- MUL1 (Mitochondrial E3 Ubiquitin Protein Ligase 1 (MUL1))
- Background
- C1orf166 encodes an ubiquitin-protein ligase that plays a role in the control of mitochondrial morphology. Promotes mitochondrial fragmentation and influences mitochondrial localization. Inhibits cell growth. When overexpressed, activates JNK through MAP3K7/TAK1 and induces caspase-dependent apoptosis. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates.
- Molecular Weight
- 40 kDa
-